CAR-T 细胞:改善儿童肿瘤结局所缺失的一环? CAR T cells: the missing piece needed to improve outcomes for children with cancer? PubMed 2026/01/16 发表J Immunother CancerQ1 · IF 11.7(JCR 2025) 人群:儿童靶点:CD19靶点:CD22靶点:CD30技术:CAR-T技术:双特异性抗体
儿童、青少年及年轻成人非霍奇金淋巴瘤的细胞与体液免疫治疗 Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma. PubMed 2023/02/02 发表Best Pract Res Clin HaematolQ2 · IF 3.4(JCR 2025) 人群:儿童人群:成人靶点:CD19靶点:CD20靶点:CD22技术:CAR-NK技术:NK 细胞技术:双特异性抗体
规模化与扩大应用:工程化 T 细胞治疗生产的进展与挑战 Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies. PubMed 2022/04/29 发表Int Rev ImmunolQ2 · IF 5.4(JCR 2025) 靶点:CD19靶点:CD22靶点:CD30技术:CAR-T技术:TCR-T技术:双特异性抗体